How to avoid the costly pitfalls of assay scaleup

Biofortuna_YTThumbnail_1280x720_1

A multi-disciplinary panel of R&D scientists covering the entire scope of assay design and development, and a POCT regulatory approval expert discuss the many issues assay designers face when scaling up to commercialisation. Learn how to avoid the costly pitfalls that each aspect of the process can present and find out more about the regulatory approval journey for POCT assays in cartridges.

Speakers

Michaela_BrandedHeadshot

Michaela Hoffmeyer

Director of Regulatory Affairs
TE IDV Solutions

DipankarManna_BrandedHeadshot

Dipankar Manna

Senior Director of R&D

LGC Biosearch Technologies

BrianCattaneo_BrandedHeadshot

Brian Catteneo

New Product Development Staff Engineer
TE IDV Solutions

FraserYoung_BrandedHeadshot

Dr. Fraser Young

Senior Scientist
Biofortuna

Watch now

Fill out this simple form and
get immediate access: